TABLE 3.
No. Patients | No. HIV Viral Load Undetectable (%) | Univariate Analysis |
Multivariate Analysis |
|||
---|---|---|---|---|---|---|
OR | P | OR (95% CI) | P | |||
Gender | ||||||
Male | 443 | 300 (68%) | ||||
Female | 155 | 115 (74%) | 1.4 | 0.133 | 1.5 (0.9–2.3) | 0.077 |
Age (y) when HAART started | ||||||
<31 | 133 | 88 (66%) | ||||
31–40 | 265 | 176 (66%) | 1.0 | 0.960 | 1.1 (0.71–1.8) | 0.623 |
41+ | 198 | 151 (76%) | 1.6 | 0.045 | 1.8 (1.1–3.1) | 0.017 |
Not known | 2 | 0 (0%) | ||||
Exposure category | ||||||
Heterosexual contact | 437 | 307 (70%) | ||||
Homosexual contact | 98 | 75 (77%) | 1.4 | 0.215 | 1.9 (1.1–3.2) | 0.023 |
Other | 63 | 33 (52%) | 0.5 | 0.005 | 0.4 (0.2–0.6) | 0.001 |
Baseline viral load test (copies/mL) | ||||||
<5000 | 78 | 57 (73%) | ||||
5000+ | 299 | 196 (66%) | 0.7 | 0.209 | 0.7 (0.4–1.2) | 0.170 |
Not tested before | 221 | 162 (73%) | 1.0 | 0.969 | 0.8 (0.5–1.6) | 0.569 |
HAART (3 or more drugs) | ||||||
NRTI ± PI − NNRTI | 260 | 166 (64%) | ||||
NRTI + NNRTI − PI | 312 | 229 (73%) | 1.6 | 0.014 | 1.7 (1.2–2.6) | 0.006 |
NNRTI + PI ± NRTI | 26 | 20 (77%) | 1.9 | 0.188 | 2.0 (0.8–5.2) | 0.168 |
Having mono/double therapy before starting HAART | ||||||
No | 380 | 273 (72%) | ||||
Yes | 218 | 142 (65%) | 0.7 | 0.087 | 0.7 (0.5–1.0) | 0.067 |